Insights Into CF (CF) Q4: Wall Street Projections for Key Metrics
https://www.zacks.com/stock/news/2224005/insights-into-cf-cf-q4-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224005
Feb 09, 2024 - Evaluate the expected performance of CF (CF) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
0
CF (CF) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2226492/cf-cf-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2226492
Feb 14, 2024 - While the top- and bottom-line numbers for CF (CF) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Company News for Feb 16, 2024
https://www.zacks.com/stock/news/2227473/company-news-for-feb-16-2024?cid=CS-ZC-FT-corporate_summary-2227473
Feb 16, 2024 - Companies in The News Are:HBI,WEN,ET,CF
0
Design a Balanced Portfolio With These 4 Low P/CF Stocks
https://www.zacks.com/stock/news/2248414/design-a-balanced-portfolio-with-these-4-low-p-cf-stocks?cid=CS-ZC-FT-analyst_blog|rw-2248414
Apr 01, 2024 - Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. ATGE, GM, UNM & KBH boast low P/CF ratios.
0
Nutrien (NTR) Gains on Strong Demand Amid Pricing Woes
https://www.zacks.com/stock/news/2253953/nutrien-ntr-gains-on-strong-demand-amid-pricing-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2253953
Apr 11, 2024 - While Nutrien (NTR) faces pricing headwinds, it benefits from solid demand for fertilizers, backed by the strength in global agriculture markets.
0
Pick These 4 Low P/CF Stocks to Boost Your Portfolio
https://www.zacks.com/stock/news/2255409/pick-these-4-low-p-cf-stocks-to-boost-your-portfolio?cid=CS-ZC-FT-analyst_blog|rw-2255409
Apr 15, 2024 - Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. PAGS, ATGE, KBH & GM boast a low P/CF ratio.
0
EQT to pursue 500M cf/day Mountain Valley Pipeline expansion
https://seekingalpha.com/news/4093770-eqt-to-pursue-500m-cfday-mountain-valley-pipeline-expansion?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Apr 24, 2024 - EQT plans to expand the capacity of the Mountain Valley Pipeline after acquiring Equitrans Midstream, in response to increased gas demand in the southeast U.S.
0
Vertex to seek FDA, EMA approval for CF therapy by mid-2024
https://seekingalpha.com/news/4062897-vertex-to-seek-fda-ema-approval-for-vanza-triple-therapy-for-cf?source=feed_sector_healthcare
Feb 05, 2024 - Vertex Pharmaceuticals (VRTX) reported positive Phase 3 study results for its vanza triple therapy in the treatment of cystic fibrosis and plans to seek US and
0
Pages: 1
Page 1